REGENCELL BIOSCIENCE HOLDINGS LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • July 20th, 2021 • Regencell Bioscience Holdings LTD • Medicinal chemicals & botanical products • New York
The undersigned, Regencell Bioscience Holdings Limited, a corporation incorporated under the laws of the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), (A) an aggregate of 2,300,000 ordinary shares (the “Firm Shares”) par value $0.00001 per share of the Company (“Ordinary Shares”) and (B) at the election of the Representative, (i) up to an additional 345,000 Ordinary Shares (the “Option Shares”, and together with the Firm Shares, the “Shares”). The offering and sale of the Shares contemplated by this Agreement is referred to herein as the “Offering”.
